Connect with us

Cannabis News

Times of CBD Weekly Recap: Five of the Biggest Cannabidiol-Centric Events to Happen

Published

on

weekly cbd events roundup

Five Noteworthy Events in CBD Industry

Medical Marijuana Smuggling Charges Upheld by Minnesota Court

The Minnesota Court of Appeals affirmed a trial court ruling where two cannabis company officials were charged with smuggling medical marijuana from Minnesota to New York. The defense’s arguments did not sway the court, and Assistant County Attorney Shane Simonds commented on the appellate decision. He stated “All these regulations in Minnesota are saying here is where these substances and chemicals can go and it’s very limited…and the bottom line is if it’s made in Minnesota, it stays in Minnesota.”

NFL Medical Task Force to Study Marijuana

According to a recent article by the Washington Post, the NFL and the NFL Players Association are cooperating on a study concerning medical marijuana as a pain management resource for players. Allen Sills, the league’s chief medical office said in a phone interview with the publication,

“I think it’s a proud day for the NFL and the NFLPA to come together on these issues in a very public way, I think it demonstrates the spirit of cooperation we have around our health and safety issues. … Both of these committees are about providing the best health care we can to players.”

Legislation on State Chartered Cannabis in California

Bill 51, to establish state-chartered cannabis banks, is on its way to the state’s assembly for a vote and then the governor’s signature. CNBC reported on the legislation and it is meant to help licensed marijuana businesses acquire gain access to financial institutions. According to California Senate Majority Leader Robert Hertzberg,

“As policymakers, we have a duty to further the will of the voters while protecting the public safety of our constituents,. This measure is by no means the ultimate solution, but it’s just one small step in the right direction to get some of this money off the streets and into bank accounts.”

Maine and Adult Use Regulations

Maine is working on its adult-use marijuana market. The state released draft rules, which are the proposed regulations. According to Erik Gundersen, director of the state’s Office of Marijuana Policy, “There has been a significant public interest in the adult use rules being developed in Maine, which is why we invite the public to review these rules and offer their feedback.”

National Cannabis Industry Lobbying Events

Lastly, the National Cannabis Industry is hosting lobbying events. The events can be viewed in the lobbying days archives, here.

Denis is one of the most experienced researchers for reviews we have with years of experience in writing about CBD products. He will be one of the most viewed authors due to his own thrill in sharing what he is learning about cannabidiol and supplement use. With a goal of providing clarity within the budding CBD oil industry, Denis will be spending much of the year going through a catalogue of cannabis oil companies in the near future.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.